Bertok T, Jane E, Hires M, Tkac J
Cancers (Basel). 2024; 16(22).
PMID: 39594740
PMC: 11592093.
DOI: 10.3390/cancers16223786.
Kirschenbaum A, Cheung P, Rajagopalan V, Yao S, Milgrim L, Kyprianou N
Am J Clin Exp Urol. 2024; 12(5):255-265.
PMID: 39584003
PMC: 11578768.
DOI: 10.62347/DZIU5992.
Mladenovic M, Jaric S, Mundzic M, Pavlovic A, Bobrinetskiy I, Knezevic N
Biosensors (Basel). 2024; 14(7).
PMID: 39056602
PMC: 11274377.
DOI: 10.3390/bios14070326.
Dahiya V, Hans S, Kumari R, Bagchi G
Clin Transl Oncol. 2024; 26(10):2444-2456.
PMID: 38744755
DOI: 10.1007/s12094-024-03508-2.
Lehtonen M, Kellokumpu-Lehtinen P
SAGE Open Med. 2023; 11:20503121231216837.
PMID: 38050625
PMC: 10693792.
DOI: 10.1177/20503121231216837.
Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study.
Lima T, Barros A, Trindade F, Ferreira R, Leite-Moreira A, Barros-Silva D
Cancers (Basel). 2022; 14(8).
PMID: 35454907
PMC: 9031064.
DOI: 10.3390/cancers14082001.
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
Ramirez-Garrastacho M, Bajo-Santos C, Line A, Martens-Uzunova E, de la Fuente J, Moros M
Br J Cancer. 2021; 126(3):331-350.
PMID: 34811504
PMC: 8810769.
DOI: 10.1038/s41416-021-01610-8.
Development of Parallel Reaction Monitoring Assays for the Detection of Aggressive Prostate Cancer Using Urinary Glycoproteins.
Dong M, Lih T, Hoti N, Chen S, Ponce S, Partin A
J Proteome Res. 2021; 20(7):3590-3599.
PMID: 34106707
PMC: 8631583.
DOI: 10.1021/acs.jproteome.1c00162.
Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis.
Ding G, Sun J, Jiang L, Gao P, Zhou Q, Wang J
Open Med (Wars). 2020; 15(1):1039-1047.
PMID: 33336059
PMC: 7718645.
DOI: 10.1515/med-2020-0237.
Urinary glycoproteins associated with aggressive prostate cancer.
Dong M, Lih T, Chen S, Cho K, Eguez R, Hoti N
Theranostics. 2020; 10(26):11892-11907.
PMID: 33204318
PMC: 7667684.
DOI: 10.7150/thno.47066.
A piece in prostate cancer puzzle: Future perspective of novel molecular signatures.
Nassir A
Saudi J Biol Sci. 2020; 27(4):1148-1154.
PMID: 32256177
PMC: 7105665.
DOI: 10.1016/j.sjbs.2020.02.003.
Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
Bowden S, Foster B
Adv Exp Med Biol. 2019; 1148:279-322.
PMID: 31482504
DOI: 10.1007/978-981-13-7709-9_13.
Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
Drabovich A, Saraon P, Drabovich M, Karakosta T, Dimitromanolakis A, Hyndman M
Mol Cell Proteomics. 2019; 18(9):1807-1823.
PMID: 31249104
PMC: 6731075.
DOI: 10.1074/mcp.RA119.001612.
Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?.
Xu H, Wang F, Li H, Ji J, Cao Z, Lyu J
Dis Markers. 2019; 2019:7090545.
PMID: 30809318
PMC: 6364107.
DOI: 10.1155/2019/7090545.
History of the discovery and clinical translation of prostate-specific antigen.
Catalona W
Asian J Urol. 2018; 1(1):12-14.
PMID: 29511633
PMC: 5832880.
DOI: 10.1016/j.ajur.2014.09.008.
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Sarwar S, Adil M, Nyamath P, Ishaq M
Prostate Cancer. 2017; 2017:5687212.
PMID: 28168057
PMC: 5266858.
DOI: 10.1155/2017/5687212.
Can glycoprofiling be helpful in detecting prostate cancer?.
Belicky S, Tkac J
Chem Zvesti. 2016; 69(1):90-111.
PMID: 27257317
PMC: 4886849.
DOI: 10.1515/chempap-2015-0052.
Prostate cancer markers: An update.
Pentyala S, Whyard T, Pentyala S, Muller J, Pfail J, Parmar S
Biomed Rep. 2016; 4(3):263-268.
PMID: 26998261
PMC: 4774403.
DOI: 10.3892/br.2016.586.
Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.
Kanyong P, Rawlinson S, Davis J
J Cancer. 2016; 7(5):523-31.
PMID: 26958088
PMC: 4780128.
DOI: 10.7150/jca.13821.
Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.
Dmitriev A, Rosenberg E, Krasnov G, Gerashchenko G, Gordiyuk V, Pavlova T
Dis Markers. 2015; 2015:241301.
PMID: 26491211
PMC: 4602334.
DOI: 10.1155/2015/241301.
